Skip to content
October 04, 2022

Equity.Guru

Investment information for the new generation

preclinical studies

Numinus Wellness (NUMI.T) research lab, Numinus Bioscience, received the nod from the Public Health Agency of Canada for their containment level 2 (CL2) pathogens and toxins license after the…
Should You Care About Else Nutrition? Else Nutrition Holdings Inc. (BABY.T) announced on February 22, 2022, that it has concluded a successful preclinical study on its Plant-Based Infant Formula….
Psyched Wellness (PSYC.C) has signed an additional agreement with its contract research organization partner, KGK Science, to further study the anti inflammatory nature of AME-1. “This is a key…
Algernon Pharmaceuticals (AGN.C) has established a clinical trial program to treat stroke that uses DMT, or (N-dimethyltryptamine) today, according to a press release. The company decided to take a…